Ablynx Will Announce Half-Year Results For 2009 With Webcast PharmaLive.com (press release) – Newtown,PA,USA ALX-0681, a subcutaneous formulation of the novel anti-thrombotic Nanobodies® that also selectively targets von Willebrand factor (vWF) has concluded Phase …
When a patient fills a prescription at a major pharmacy, a record of that prescription (minus the patient name) is sold to companies – so-called health information organizations – that pool information from multiple pharmacies. The bundled information is combined with individual physician identities purchased from the American Medical Association to create prescriber profiles (name, […]
I have an admission. I am not particularly proud of myself, but I got a D- in High School Biology. Normally, I wouldn’t share something this personal in this space, but I do so to illustrate a point. In High School, I couldn’t look at the model of the double helix in class without thinking […]
Check out the video of community members Nathan and Sonji Wilkes, interviewed by Dr. Nancy on MSNBC today!
Ablynx Announces Positive Phase I Results for Subcutaneous Administration of it's Ant-thrombotic NanobodyR (ALX-0681)
GHENT, Belgium, 18 August 2009 – Ablynx [Euronext Brussels: ABLX] today announced the positive results from its double-blind, randomized, placebo-controlled, single and multiple dose Phase I study with ALX-0681, a subcutaneous formulation of its novel anti-thrombotic Nanobody® that selectively targets von Willebrand factor (vWF). The positive Phase I data support the progression of ALX-0681 towards […]
Francis S. Collins, M.D., Ph.D., NIH Director Francis S. Collins, M.D., Ph.D., was officially sworn in on Monday, August 17, 2009 as the 16th director of the National Institutes of Health (NIH). Dr. Collins was nominated by President Barack Obama on July 8, and was unanimously confirmed by the U.S. Senate on August 7. Dr. […]
In 2008, New York took an active approach to increasing the use of palliative care by educating health care professionals about this form of care and its potential benefits passing Senate Bill 2108. SB 2108 provided $4.5 million in grants from the state’s public health budget to recruit faculty for and develop programs in health […]
2009 Meeting Materials of the Blood Products Advisory Committee Transcripts of the 7/20-21/2009 Meeting, Posted: 8/18/2009
Nathan Wilkes and his family have truly inspired the community to share their stories and let their VOICES be heard. To read Nathan’s entire introduction on August 15, 2009 CLICK HERE.
Nathan Wilkes, a bleeding disorders community member, had the opportunity to introduce President OBAMA today at a townhall meeting in Grand Junction, CO. Before the introduction, he highlighted how his 6-year old son with hemophilia nearly reached the lifetime insurance cap. He emphasized his family’s concerns with health insurance coverage. HFA is excited Nathan had the opportunity to represent the […]
Assisting and Advocating for the Bleeding Disorders Community